Paris, France, Cambridge (Massachusetts, United States), September 4, 2023 – 11:00 p.m. – Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a biotechnology company at the clinic specializing in the development of treatments that aim to slow the degenerative processes associated with aging and improve the functional results of patients suffering from age-related diseases, including respiratory failure in patients suffering from COVID-19, announces that its CEO, Stanislas Veillet, will participate and make a presentation at the “HC Wainwright 25th Annual Global Investment Conference”, which is being held from September 11 to 13, 2023 in New York.
2023-09-04 21:00:00
#Biophytis #participate #25th #Global #Investment #Conference #Wainwright #York
